Intracellular versus extracellular inhibition of calpain I causes differential effects on pain in a rat model of joint inflammation.
Jason J McDougallMiranda McConnellAllison R ReidPublished in: Molecular pain (2022)
Calpain I is a calcium-dependent cysteine protease which has dual effects on tissue inflammation depending on its cellular location. Intracellularly, calpain I has pro-inflammatory properties but becomes anti-inflammatory when exteriorised into the extracellular space. In this study, the effect of calpain I on joint pain was investigated using the kaolin/carrageenan model of acute synovitis. Evoked pain behaviour was determined by von Frey hair algesiometry and non-evoked pain was measured using dynamic hindlimb weight bearing. Local administration of calpain I reduced secondary allodynia in the acute inflammation model and this effect was blocked by the cell impermeable calpain inhibitor E-64c. Calpain I also blocked the algesic effect of the protease activated receptor-2 (PAR-2) cleaving enzyme mast cell tryptase. The cell permeable calpain blocker E-64d also produced analgesia in arthritic joints. These data suggest that calpain I produces disparate effects on joint pain viz. analgesia when present extracellularly by disarming PAR-2, and pro-algesic when the enzyme is inside the cell.
Keyphrases
- pain management
- chronic pain
- neuropathic pain
- oxidative stress
- single cell
- anti inflammatory
- cell therapy
- liver failure
- postoperative pain
- physical activity
- stem cells
- spinal cord injury
- body mass index
- mass spectrometry
- spinal cord
- machine learning
- mesenchymal stem cells
- electronic health record
- bone marrow
- high resolution
- artificial intelligence
- deep learning
- drug induced
- angiotensin ii
- living cells
- fluorescent probe
- body weight